Our previous studies demonstrated that PML is a growth suppressor that
suppresses oncogenic transformation of NIH/3T3 cells and rat embryo f
ibroblasts. PML is a nuclear matrix-associated phosphoprotein whose ex
pression is regulated during the cell cycle, Disruption of PML functio
n by t(15;17) in acute promyelocytic leukemia (APL) plays a critical r
ole in leukemogenesis, To further study the role of PML in the control
of cell growth, we have stably overexpressed PML protein in the HeLa
cell line, This overexpression of PML significantly reduced the growth
rate of HeLa cells and suppressed anchorage-independent growth in sof
t agar. We consequently investigated several parameters correlated wit
h cell growth and cell cycle progression, We found that, in comparison
with the parental HeLa cells, HeLa/PML stable clones showed proportio
nally more cells in G1 phase, fewer cells in S phase and about the sam
e number in G2/M phase, The HeLa/PML clones showed a significantly lon
ger doubling time as a result of a lengthening of the G1 phase, No eff
ect on apoptosis was found in HeLa cells overexpressing PML, This obse
rvation indicates that PML suppresses cell growth by increasing cell c
ycle duration as a result of G1 elongation, To further understand the
mechanism of the effect of PML on HeLa cells, expression of cell cycle
-related proteins in HeLa/PML and parental HeLa cells was analyzed, We
found that Rb phosphorylation was significantly reduced in PML stable
clones, Expression of cyclin E, Cdk2 and p27 proteins was also signif
icantly reduced, These studies indicate that PML affects cell cycle pr
ogression by mediating expression of several key proteins that normall
y control cell cycle progression, These results further extend our cur
rent understanding of PML function in human cells and its important ro
le in cell cycle regulation.